Tuba B.
About Tuba B.
Tuba B. is the Director, Clinical Capabilities Lead at the Clinical Center of Excellence at Bristol Myers Squibb in New Jersey, with extensive experience in oncology research and clinical trial methodologies.
Current Position at Bristol Myers Squibb
Tuba B. is currently the Director, Clinical Capabilities Lead, at the Clinical Center of Excellence, Bristol Myers Squibb, located in New Jersey, United States. In her role, she leads the Clinical Capabilities team, focusing on the implementation of innovative clinical trial methodologies.
Previous Roles at Bristol Myers Squibb
Before her current role, Tuba B. served as the Associate Director in Late Clinical/ Global Drug Development, Clinical Science, at Bristol Myers Squibb, for eight months between 2020 and 2021. This role also took place in New Jersey, United States.
Tenure at Merck
At Merck, Tuba B. worked as a Senior Clinical Scientist on the Keytruda Lung Program between 2018 and 2020 in North Wales, Pennsylvania. Prior to this, she held the position of Clinical Scientist from 2017 to 2018, focusing on Keytruda, a significant immunotherapy drug for lung cancer.
Academic Research Positions
Tuba B. has a solid academic background with post-doctoral roles at various institutions. She was a Post-Doctoral Researcher at Translational and Biomarker Research, Oncology Platform at EMD Serono, Inc., from 2015 to 2017. She also held similar positions at the Albert Einstein College of Medicine, focusing on cancer research from 2013 to 2015, and at the Biomedical Engineering Department, Worcester Polytechnic Institute, from 2011 to 2013. Additionally, Tuba B. worked at the University of Massachusetts Medical School as a Graduate Student and Mentor between 2001 to 2010.
Educational Background
Tuba B. holds a Doctor of Philosophy (Ph.D.) from the University of Massachusetts Medical School. She also achieved a Master of Science (M.Sc.) and a Bachelor of Science (B.Sc.) from Boğaziçi University. She has been involved in various international research collaborations, enriching her expertise and contributing to global scientific knowledge.
Early Career and Internships
Earlier in her career, Tuba B. worked as an Instructor at the Information Technology Department of Istanbul Bilgi University from 1998 to 2000. She also completed a three-month Research Internship at the Institute of Chemical Technology under TUBITAK (Scientific and Technical Research Council of the Turkish Republic) in 1996.
Contributions to Clinical Research
Tuba B. has extensive experience in oncology research, particularly in translational and biomarker research. During her tenure at Merck, she contributed significantly to the development and clinical trials of Keytruda for lung cancer.